Rapid Micro Biosystems (RPID) Competitors $2.19 -0.36 (-14.27%) As of 03:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RPID vs. LAB, EYPT, ALNT, QTRX, QSI, AEHR, FEIM, MASS, KEQU, and NAUTShould you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Allient (ALNT), Quanterix (QTRX), Quantum-Si (QSI), Aehr Test Systems (AEHR), Frequency Electronics (FEIM), 908 Devices (MASS), Kewaunee Scientific (KEQU), and Nautilus Biotechnology (NAUT). These companies are all part of the "measuring and control equipment" industry. Rapid Micro Biosystems vs. Standard BioTools EyePoint Pharmaceuticals Allient Quanterix Quantum-Si Aehr Test Systems Frequency Electronics 908 Devices Kewaunee Scientific Nautilus Biotechnology Standard BioTools (NASDAQ:LAB) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, community ranking, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability. Does the media refer more to LAB or RPID? In the previous week, Rapid Micro Biosystems had 1 more articles in the media than Standard BioTools. MarketBeat recorded 1 mentions for Rapid Micro Biosystems and 0 mentions for Standard BioTools. Rapid Micro Biosystems' average media sentiment score of 1.43 beat Standard BioTools' score of 0.00 indicating that Rapid Micro Biosystems is being referred to more favorably in the news media. Company Overall Sentiment Standard BioTools Neutral Rapid Micro Biosystems Positive Do analysts prefer LAB or RPID? Standard BioTools currently has a consensus price target of $2.50, indicating a potential upside of 133.64%. Rapid Micro Biosystems has a consensus price target of $8.00, indicating a potential upside of 213.73%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Standard BioTools.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Standard BioTools 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Rapid Micro Biosystems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Which has more volatility & risk, LAB or RPID? Standard BioTools has a beta of 1.62, indicating that its stock price is 62% more volatile than the S&P 500. Comparatively, Rapid Micro Biosystems has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Is LAB or RPID more profitable? Standard BioTools has a net margin of -79.92% compared to Rapid Micro Biosystems' net margin of -184.93%. Standard BioTools' return on equity of -27.05% beat Rapid Micro Biosystems' return on equity.Company Net Margins Return on Equity Return on Assets Standard BioTools-79.92% -27.05% -15.52% Rapid Micro Biosystems -184.93%-48.05%-39.18% Which has stronger valuation & earnings, LAB or RPID? Rapid Micro Biosystems has lower revenue, but higher earnings than Standard BioTools. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStandard BioTools$174.43M2.32-$74.66M-$0.55-1.95Rapid Micro Biosystems$28.05M3.93-$52.47M-$1.08-2.36 Do insiders and institutionals have more ownership in LAB or RPID? 53.7% of Standard BioTools shares are held by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are held by institutional investors. 53.1% of Standard BioTools shares are held by insiders. Comparatively, 30.4% of Rapid Micro Biosystems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community prefer LAB or RPID? Rapid Micro Biosystems received 1 more outperform votes than Standard BioTools when rated by MarketBeat users. However, 83.33% of users gave Standard BioTools an outperform vote while only 35.29% of users gave Rapid Micro Biosystems an outperform vote. CompanyUnderperformOutperformStandard BioToolsOutperform Votes583.33% Underperform Votes116.67%Rapid Micro BiosystemsOutperform Votes635.29% Underperform Votes1164.71% SummaryStandard BioTools beats Rapid Micro Biosystems on 11 of the 19 factors compared between the two stocks. Remove Ads Get Rapid Micro Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RPID vs. The Competition Export to ExcelMetricRapid Micro BiosystemsAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$110.25M$4.28B$5.54B$7.50BDividend YieldN/A0.54%4.86%4.04%P/E Ratio-2.2827.8023.2218.08Price / Sales3.934.18363.5486.83Price / CashN/A36.2438.1634.64Price / Book0.921.606.513.99Net Income-$52.47M-$83.57M$3.21B$247.18M7 Day Performance-4.85%-5.69%-4.88%-4.25%1 Month Performance3.24%-12.11%-0.06%-6.87%1 Year Performance161.54%-36.79%6.62%-3.73% Rapid Micro Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RPIDRapid Micro Biosystems1.5162 of 5 stars$2.20-13.7%$8.00+263.6%+165.7%$95.99M$28.05M-1.98200News CoveragePositive NewsGap DownLABStandard BioTools1.9658 of 5 stars$1.15-5.0%$2.88+150.0%-59.8%$435.83M$174.43M-1.62620EYPTEyePoint Pharmaceuticals1.5346 of 5 stars$6.34+1.4%$26.63+320.0%-76.0%$435.74M$43.27M-3.17120Positive NewsGap UpALNTAllient4.4454 of 5 stars$24.12+1.3%$31.00+28.5%-38.9%$406.30M$529.97M27.411,950Positive NewsQTRXQuanterix2.7719 of 5 stars$7.19-0.4%$20.75+188.6%-71.7%$278.80M$135.44M-6.78460Positive NewsGap DownQSIQuantum-Si2.2589 of 5 stars$1.48+1.7%$3.48+134.8%-37.0%$271.05M$3.06M-2.31150Gap UpAEHRAehr Test Systems3.2577 of 5 stars$9.06+1.8%$25.00+175.9%-41.0%$269.19M$50.74M12.0890Upcoming EarningsNews CoverageGap DownFEIMFrequency Electronics2.543 of 5 stars$16.68+2.6%N/A+45.8%$161.41M$65.40M20.34200Positive NewsGap DownMASS908 Devices3.0472 of 5 stars$4.24-6.4%$5.33+25.8%-43.4%$149.80M$59.63M-2.4060Short Interest ↑KEQUKewaunee Scientific2.1044 of 5 stars$44.96-3.3%N/A+6.1%$128.36M$220.03M7.131,006Gap DownNAUTNautilus Biotechnology2.5495 of 5 stars$1.00+1.0%$2.42+141.7%-72.9%$126.12MN/A-1.79130Short Interest ↑News CoverageGap Down Remove Ads Related Companies and Tools Related Companies Standard BioTools Alternatives EyePoint Pharmaceuticals Alternatives Allient Alternatives Quanterix Alternatives Quantum-Si Alternatives Aehr Test Systems Alternatives Frequency Electronics Alternatives 908 Devices Alternatives Kewaunee Scientific Alternatives Nautilus Biotechnology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RPID) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredEU’s Action Takes Aim At US RetireesTrump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout? With President Trump back and...Colonial Metals | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapid Micro Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapid Micro Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RPID Stock Free RPID Stock Alerts